Breakthroughs Changing The Diagnosis And Treatment Of Alzheimer’s

COVID Can Cause Alzheimer's-Like Plaques in Eyes And Brain

COVID-19 could lead to a protein build-up similar to that seen in Alzheimer's patients – not just in the brain, but also in the eyes, according to a new study. This may explain why 'brain fog', an umbrella term for issues with memory or cognition, is often reported as a symptom of COVID-19. In a new study led by Yale University, researchers sought to illuminate apparent similarities between COVID brain fog and Alzheimer's, investigating whether …

First-Ever Brain Imaging Of Nasal Insulin Brings Scientists Closer To New Alzheimer’s Therapy

Nasal insulin therapy has emerged as a potential approach for Alzheimer’s because it bypasses the bloodstream and travels directly to the brain along nerve pathways. The post First-Ever Brain Imaging Of Nasal Insulin Brings Scientists Closer To New Alzheimer’s Therapy appeared first on Study Finds.

Breakthroughs Changing The Diagnosis And Treatment Of Alzheimer’s

New blood-based biomarker tests for amyloid and disease-modifying treatments have recently become available for Alzheimer's disease patients.

New Study Validates Insulin Nasal Spray to Deliver Alzheimer’s Drug Directly to the Brain

A groundbreaking brain imaging study from Wake Forest University School of Medicine confirms a vital step toward new Alzheimer's disease treatments: Intranasal insulin, delivered via a simple nasal spray, safely and effectively reaches key memory regions of the brain in older adults. The study also revealed that people with early cognitive decline absorb it differently.

Where Alzheimer’s disease is hitting the hardest in the U.S.

A new study has found that Alzheimer’s disease, a serious illness that affects memory and thinking, is most common in the East and Southeast parts of the United States. This includes places like Florida, Maryland, and parts of New York. These areas have the highest numbers of older people living with Alzheimer’s. Alzheimer’s disease mostly […] The post Where Alzheimer’s disease is hitting the hardest in the U.S. appeared first on Knowridge Scien…

Roche’s Elecsys pTau181 test gains CE Mark to rule out Alzheimer's

Roche’s Elecsys pTau181 test has secured CE Mark approval, marking a development in ruling out Alzheimer's disease.The post Roche’s Elecsys pTau181 test gains CE Mark to rule out Alzheimer’s appeared first on Medical Device Network.